c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial18 December, 2025Quantitative characterization of membrane-protein reversible association using FCS18 December, 2025 Share admin